STAT

Opinion: Women should be in biotech and health care boardrooms. But mandating they be there is not the answer

True change in the life sciences sector will come only when it adopts a comprehensive approach to diversity for everyone — not with a signature on a bill requiring companies…

A bill that made its way through the California House and Senate is now sitting on Gov. Jerry Brown’s desk, waiting to be signed. If that happens, public companies headquartered in California would be required to have at least one woman on their boards of directors by the end of 2019; companies whose boards have five or more directors will need to include two or three women by the end of 2021.

The of this legislation is right on target:

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks